We are live on ! Find out more
EDIT icon

Editas Medicine

311 hedge funds and large institutions have $3.72B invested in Editas Medicine in 2020 Q4 according to their latest regulatory filings, with 104 funds opening new positions, 87 increasing their positions, 69 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

235% more first-time investments, than exits

New positions opened: 104 | Existing positions closed: 31

140% more capital invested

Capital invested by funds: $1.55B → $3.72B (+$2.17B)

40% more call options, than puts

Call options by funds: $188M | Put options by funds: $134M

30% more funds holding

Funds holding: 239311 (+72)

26% more repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 69

3.56% less ownership

Funds ownership: 88.57%85.02% (-3.6%)

Holders
311
Holders Change
+72
Holders Change %
+30.13%
% of All Funds
5.5%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
104
Increased
87
Reduced
69
Closed
31
Calls
$188M
Puts
$134M
Net Calls
+$53.9M
Net Calls Change
+$35M
Name Holding Trade Value Shares
Change
Change in
Stake
New York State Common Retirement Fund
51
New York State Common Retirement Fund
New York
$4.92M +$232K +5,650 +9%
NIA
52
NIA Impact Advisors
California
$4.9M +$2.24M +54,615 New
Jacobs Levy Equity Management
53
Jacobs Levy Equity Management
New Jersey
$4.86M -$849K -20,675 -23%
UBS AM
54
UBS AM
Illinois
$4.82M +$483K +11,753 +21%
MSL
55
Mackay Shields LLC
New York
$4.75M +$246K +6,000 +10%
CSS
56
Cubist Systematic Strategies
Connecticut
$4.71M +$1.47M +35,854 +115%
State of New Jersey Common Pension Fund D
57
State of New Jersey Common Pension Fund D
New Jersey
$4.48M -$65.5K -1,594 -2%
Fidelity Investments
58
Fidelity Investments
Massachusetts
$4.36M +$770K +18,745 +43%
RJA
59
Raymond James & Associates
Florida
$4.3M -$829K -20,192 -25%
RJFSA
60
Raymond James Financial Services Advisors
Florida
$4.26M +$519K +12,623 +26%
Millennium Management
61
Millennium Management
New York
$4.21M +$2.47M +60,125 New
LPL Financial
62
LPL Financial
California
$4.19M +$94.6K +2,304 +4%
Victory Capital Management
63
Victory Capital Management
Texas
$3.99M -$372K -9,056 -14%
Russell Investments Group
64
Russell Investments Group
United Kingdom
$3.98M -$2.24M -54,562 -49%
SCM
65
Shelton Capital Management
Colorado
$3.79M +$781K +19,000 +54%
Deutsche Bank
66
Deutsche Bank
Germany
$3.72M +$585K +14,252 +37%
HAM
67
HHR Asset Management
New Jersey
$3.54M -$719K -17,510 -26%
ETC
68
Exchange Traded Concepts
Oklahoma
$3.54M +$1.62M +39,346 +355%
MFAM
69
Motley Fool Asset Management
Virginia
$3.38M +$357K +8,700 +22%
Citadel Advisors
70
Citadel Advisors
Florida
$2.88M -$5.98M -145,594 -78%
Citigroup
71
Citigroup
New York
$2.85M -$1.15M -28,071 -41%
First Trust Advisors
72
First Trust Advisors
Illinois
$2.83M +$389K +9,462 +31%
Invesco
73
Invesco
Georgia
$2.79M +$1.12M +27,156 +215%
Los Angeles Capital Management
74
Los Angeles Capital Management
California
$2.72M -$279K -6,790 -15%
Thrivent Financial for Lutherans
75
Thrivent Financial for Lutherans
Minnesota
$2.7M

EDIT Hedge Fund Activity: Q4 2020 in Review

311 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q4 2020, worth a combined $3.72B — up 140% from $1.55B a quarter earlier.

Buyers outnumbered sellers: 104 funds opened new EDIT positions and 31 closed out — a net gain of 73 holders — while 87 added to existing stakes and 69 trimmed.

The largest buyer was D.E. Shaw & Co, adding an estimated $16.8M. The largest seller was Nikko Asset Management Americas, cutting an estimated $28.2M.

  • 311 institutional investors held Editas Medicine (EDIT) as of Q4 2020, up from 239 in Q3 2020.
  • Funds reported $3.72B of Editas Medicine stock for Q4 2020, up 140% quarter-over-quarter.
  • 104 funds opened new Editas Medicine positions in Q4 2020 and 31 closed out, a net change of +73 holders.
  • The largest Editas Medicine buyer in Q4 2020 was D.E. Shaw & Co, an estimated $16.8M added.
  • The largest Editas Medicine seller in Q4 2020 was Nikko Asset Management Americas, an estimated $28.2M sold.

Based on aggregated 13F filings for Q4 2020.